Venus Remedies Secures Five Marketing Authorisations Across Four Key Global Markets
Venus Remedies Ltd 路 Others (Uncategorized) 路 16 Oct 2026, 8:25 pm
Venus Remedies Secures Five Marketing Authorisations Across Four Key Global Markets Venus Remedies Limited secured five marketing authorisations across Kazakhstan, Peru, Kuwait, and Argentina on 16th Oct'26, expanding its footprint across the CIS, Latin America, and Middle East regions. Key approvals include Vancomycin and Fluorouracil in Kazakhstan, Fulvestrant in Peru, Methotrexate in Kuwait, and Meropenem in Argentina. The regulatory clearances strengthen the company鈥檚 critical-care injectables and oncology export portfolio, reinforcing its global growth strategy across high-potential international markets.
Original exchange filing (PDF)
More announcements from Venus Remedies Ltd
- As per the file enclosed. 路 05 Nov 2026
- Venus Remedies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 27 Oct 2026
- As per the file enclosed. 路 27 Oct 2026
- Outcome of Board Meeting date 26th October 2026 and Unaudited Financial Results for the period ended on 30th September 2026. 路 27 Oct 2026
- As per the pdf enclosed. 路 14 Oct 2026
- VENUS REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 26-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 26 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 26 Oct 2026
- Venus Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve As per the pdf enclosed. 路 26 Oct 2026
